• Episode 12 - New Study on Treatments for Non-Alcoholic Fatty Liver Disease in People With HIV With Dr Jordan Lake Recorded Live from CROI 2024

  • Mar 12 2024
  • Length: 24 mins
  • Podcast
Episode 12 - New Study on Treatments for Non-Alcoholic Fatty Liver Disease in People With HIV With Dr Jordan Lake Recorded Live from CROI 2024  By  cover art

Episode 12 - New Study on Treatments for Non-Alcoholic Fatty Liver Disease in People With HIV With Dr Jordan Lake Recorded Live from CROI 2024

  • Summary

  • Episode 12 - New Study on Treatments for Non-Alcoholic Fatty Liver Disease in People With HIV With Dr Jordan Lake Recorded Live from CROI 2024


    In this episode, Dr Michael Saag speaks with Dr Jordan Lake live from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). They discuss the prevalence of non-alcoholic fatty liver disease (NAFLD) among people with HIV and explore the effectiveness of the GLP-1 receptor agonist semaglutide, commonly used to treat diabetes and aid in weight loss, to treat NAFLD. Future areas of research are considered, including maintenance strategies post-weight loss and a placebo-controlled version of the study.


    00:02 Introduction and Welcome


    00:44 Discussion on Non-Alcoholic Fatty Liver Disease in People With HIV


    01:56 Role of HIV in Non-Alcoholic Fatty Liver Disease


    02:43 Understanding the Inflammation and Fat Accumulation in the Liver


    04:38 Exploring the Impact of Nucleoside Therapy on Non-Alcoholic Fatty Liver Disease


    06:37 Potential Treatments for Non-Alcoholic Fatty Liver Disease


    07:35 The Role of Semaglutide in Treating Non-Alcoholic Fatty Liver Disease


    13:36 The Importance of Routine Assessment for Non-Alcoholic Fatty Liver Disease


    15:37 Exploring New Drugs for Treating Non-Alcoholic Fatty Liver Disease


    18:49 The Challenges and Future Directions in Non-Alcoholic Fatty Liver Disease Research


    22:25 Conclusion and Closing Remarks

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    Instagram
    TikTok
    ...

    Show more Show less

What listeners say about Episode 12 - New Study on Treatments for Non-Alcoholic Fatty Liver Disease in People With HIV With Dr Jordan Lake Recorded Live from CROI 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.